Delinia
Delinia is a biotechnology company that is developing novel therapeutics for treating autoimmune diseases.
2
Funding Rounds
$70.0m
Money raised
Overview
Delinia is a biotechnology company that is developing novel therapeutics for treating autoimmune diseases.
- Website:
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Je***** Gr*** |
|
- | linkedin facebook |
| Name | Phone | Social networks | |
|---|---|---|---|
| Sa***** Sa** MD Ph* |
|
- |
Funding series
Funding Series Analysis
The company Delinia has raised a total of $35m in funding over 2 rounds.
Key Insights:
- Delinia Series A round, September 2016: $35m
- Delinia Series A Funding Round September 2016: $35m
Delinia Series A round, September 2016
$35m
Delinia Series A Funding Round September 2016
$35m
Industries
Delinia is active in the following industries: